Roche will invest CHF 1.2 billion in another research and development building, the renewal of the synthetic chemical molecule production and a building for the Institute of Human Biology. The new buildings will expand the infrastructure for future innovations along the entire pharmaceutical value chain, from research to production.
Sustainability is the focus of all construction projects. We use high-quality, durable materials, reduce the energy consumption, employ regenerative energy and support biodiversity.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.